![Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer | Radiation Oncology | Full Text Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1748-717X-5-80/MediaObjects/13014_2010_Article_286_Fig2_HTML.jpg)
Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer | Radiation Oncology | Full Text
Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study | PLOS ONE
![Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study | BMC Urology | Full Text Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-021-00897-2/MediaObjects/12894_2021_897_Fig1_HTML.png)
Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study | BMC Urology | Full Text
![Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis | Journal of Urology Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis | Journal of Urology](https://www.auajournals.org/cms/asset/d1f9e067-9f87-4ecd-87b7-fe6079ba3f44/ju.0000000000001369f4.gif)
Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis | Journal of Urology
![Prostate cancer in a 61-year-old patient with high serum PSA level of... | Download Scientific Diagram Prostate cancer in a 61-year-old patient with high serum PSA level of... | Download Scientific Diagram](https://www.researchgate.net/publication/313779847/figure/fig1/AS:462442426834945@1487266274692/Prostate-cancer-in-a-61-year-old-patient-with-high-serum-PSA-level-of-1943-ng-ml.png)
Prostate cancer in a 61-year-old patient with high serum PSA level of... | Download Scientific Diagram
PSA Detection with Femtomolar Sensitivity and a Broad Dynamic Range Using SERS Nanoprobes and an Area-Scanning Method | ACS Sensors
![Biosensors | Free Full-Text | Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific Antigen Biosensors | Free Full-Text | Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific Antigen](https://www.mdpi.com/biosensors/biosensors-13-00334/article_deploy/html/images/biosensors-13-00334-g002.png)
Biosensors | Free Full-Text | Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific Antigen
![Both High and Low Serum Total Testosterone Levels Indicate Poor Prognosis in Patients with Prostate Cancer | Anticancer Research Both High and Low Serum Total Testosterone Levels Indicate Poor Prognosis in Patients with Prostate Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/37/10/5559/F1.large.jpg)
Both High and Low Serum Total Testosterone Levels Indicate Poor Prognosis in Patients with Prostate Cancer | Anticancer Research
![Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study | BMJ Open Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/7/10/e017729/F2.large.jpg)
Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study | BMJ Open
![Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial | Scientific Reports Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-02696-z/MediaObjects/41598_2021_2696_Fig1_HTML.png)
Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial | Scientific Reports
![JCM | Free Full-Text | The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy JCM | Free Full-Text | The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy](https://www.mdpi.com/jcm/jcm-12-01343/article_deploy/html/images/jcm-12-01343-g002.png)
JCM | Free Full-Text | The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
![Generation and application of polyclonal IgY antibodies specific for full-length and nicked prostate-specific antigen | Bioanalysis Generation and application of polyclonal IgY antibodies specific for full-length and nicked prostate-specific antigen | Bioanalysis](https://www.future-science.com/cms/10.4155/bio.14.172/asset/images/medium/figure1.gif)
Generation and application of polyclonal IgY antibodies specific for full-length and nicked prostate-specific antigen | Bioanalysis
![SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and](https://minio.scielo.br/documentstore/1677-6119/jVxLkMSNXSmzhDyDd34Kgvd/11234766ac4c4efdc740ea8c07f31e2138c75d3c.jpg)
SciELO - Brasil - Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL Prognosis of patients with prostate cancer and
![PSA Detection with Femtomolar Sensitivity and a Broad Dynamic Range Using SERS Nanoprobes and an Area-Scanning Method | ACS Sensors PSA Detection with Femtomolar Sensitivity and a Broad Dynamic Range Using SERS Nanoprobes and an Area-Scanning Method | ACS Sensors](https://pubs.acs.org/cms/10.1021/acssensors.6b00053/asset/images/large/se-2016-00053d_0004.jpeg)
PSA Detection with Femtomolar Sensitivity and a Broad Dynamic Range Using SERS Nanoprobes and an Area-Scanning Method | ACS Sensors
![Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging? - Clinical Genitourinary Cancer Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging? - Clinical Genitourinary Cancer](https://www.clinical-genitourinary-cancer.com/cms/asset/a0d1fb8a-493e-4be2-a336-acde32786c66/gr1.jpg)
Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging? - Clinical Genitourinary Cancer
![PSA Testing for the Pretreatment Staging and Posttreatment Management of Prostate Cancer - American Urological Association PSA Testing for the Pretreatment Staging and Posttreatment Management of Prostate Cancer - American Urological Association](https://www.auanet.org/images/Education/clinical-guidance/Prostate-Specific-Antigen-Figure-2.jpg)